# A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions

> **NCT02746068** · PHASE3 · UNKNOWN · sponsor: **Axsome Therapeutics, Inc.** · enrollment: 346 (estimated)

## Conditions studied

- Osteoarthritis, Knee

## Interventions

- **DRUG:** AXS-02
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02746068
- **Lead sponsor:** Axsome Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 346 (ESTIMATED)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02746068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02746068, "A Study to Assess the Efficacy and Safety of AXS-02 in Subjects With Knee OA Associated With Bone Marrow Lesions". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT02746068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*